MedTrace Logo

SCOOT: Sample Collection for DART

NCT05368298 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 872

Last updated 2026-05-22

No results posted yet for this study

Summary

The study will use a blood sample collected from participants to:

* Develop new ways of finding and diagnosing lung health problems, such as lung cancer.
* Develop tools which make it easier to screen people with possible lung health problems, diagnose problems earlier and with fewer tests, and start the best treatment faster.
* Help improve the early diagnosis of lung cancer, as finding lung cancer early means that it can be treated more easily and successfully.

Conditions

Sponsors & Collaborators

  • Innovate UK

    collaborator OTHER_GOV

  • Optellum

    collaborator UNKNOWN

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Cancer Research UK

    collaborator OTHER

  • GE Healthcare

    collaborator INDUSTRY

  • Roche Diagnostics GmbH

    collaborator INDUSTRY

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Prenostics

    collaborator UNKNOWN

  • University of Oxford

    lead OTHER

Principal Investigators

  • Richard Lee · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-11
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05368298 on ClinicalTrials.gov